1. Home
  2. HROW vs LZB Comparison

HROW vs LZB Comparison

Compare HROW & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HROW

Harrow Inc.

N/A

Current Price

$28.30

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo La-Z-Boy Incorporated

LZB

La-Z-Boy Incorporated

N/A

Current Price

$32.49

Market Cap

1.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
HROW
LZB
Founded
1998
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2008
1994

Fundamental Metrics

Financial Performance
Metric
HROW
LZB
Price
$28.30
$32.49
Analyst Decision
Strong Buy
Buy
Analyst Count
9
2
Target Price
★ $62.63
$41.00
AVG Volume (30 Days)
★ 635.5K
492.0K
Earning Date
11-09-2026
11-17-2026
Dividend Yield
N/A
★ 2.94%
EPS Growth
★ 71.43
5.11
EPS
N/A
★ N/A
Revenue
N/A
★ $2,349,433,000.00
Revenue This Year
$28.13
N/A
Revenue Next Year
$56.02
$3.55
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$25.76
$28.39
52 Week High
$54.98
$44.90

Technical Indicators

Market Signals
Indicator
HROW
LZB
Relative Strength Index (RSI) 47.12 59.02
Support Level $27.75 $31.33
Resistance Level $30.28 $34.09
Average True Range (ATR) 1.66 0.86
MACD 0.31 0.28
Stochastic Oscillator 35.42 70.96

Price Performance

Historical Comparison
HROW
LZB

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a world'wide producer of reclining chairs and one of the manufacturers/distributors of residential furniture in the United States. It manufacture, market, import, export, distribute and retail upholstery furniture products. In addition, it import, distribute and retail accessories and casegoods (wood) furniture products. Its reportable operating segments include the Retail segment and the Wholesale segment. Its Retail segment mainly sells upholstered furniture. Wholesale segment manufactures and imports upholstered and casegoods (wood) furniture and sells directly. The company generates majority of revenue from Wholesale segment which manufactures and imports upholstered furniture, such as recliners and motion furniture, sofas, loveseats, chairs, sectionals, modulars, etc.

Share on Social Networks: